In 2023, David P. Meeker, M.D. earned $1.35M in total compensation at Rhythm Pharmaceuticals, Inc., including $704.72K salary and $634.05K bonus. Most recently sold 29,688 shares in Feb 2025. Currently holds stock worth $30.34M. 2+ years at the helm of Rhythm Pharmaceuticals, Inc..
Compensation History
Annual executive compensation data for David P. Meeker, M.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.35M
Salary
$704.72K
Bonus
$634.05K
Other
$11.89K
Salary
$704.72KBoard Justification
The compensation philosophy is designed to attract, retain, and motivate executives while aligning their interests with those of shareholders, with a significant portion of compensation tied to performance metrics.
Bonus
$634.05KBoard Justification
The actual bonus payout for 2023 was determined based on the achievement of corporate goals at 130% of target, reflecting significant progress on key objectives made during the year.
Other Compensation
$11.89KBoard Justification
This amount includes employer matching contributions to the 401(k) plan.
Restricted Stock
Board Justification
No stock was reported as vested in 2023; only stock grants and options are included in the total compensation calculations.
Performance Metrics
The performance metrics for 2023 included corporate goals related to commercial growth and product development.
David P. Meeker, M.D.
CEO of Rhythm Pharmaceuticals, Inc.
Education
M.D. from a recognized institution.
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
January 1, 1978 - 47 years ago
CEO of Rhythm Pharmaceuticals, Inc. for
2 years 4 months (Jul 2023 - Present)
Previous Experience
Various leadership roles in the biopharmaceutical industry.
Other Rhythm Pharmaceuticals, Inc. CEOs
Holdings
Track David P. Meeker, M.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$3.96M
$3.96M
83,821 RYTM shares
What if they kept their stock?
If David P. Meeker, M.D. didn't sell their stock, today they would have:
Extra RYTM83,821 shares worth $8.77M.
This is 121.4% and $4.81M more than what they got when they sold the stock.
Insider Trading
David P. Meeker, M.D.'s recent stock transactions, purchases, and sales filed with the SEC.
$1.70M
RYTM at $57.22/share
Feb 14, 2025
Sale
$254.24K
RYTM at $59.43/share
Feb 1, 2025
Sale
$1.78M
RYTM at $39.22/share
Mar 19, 2024
Sale
99,000 shares
RYTM
Feb 16, 2024
Received
$196.51K
RYTM at $45.06/share
Feb 1, 2024
Sale
$201.71K
RYTM at $20.17/share
Mar 30, 2021
Purchase
$425.00K
RYTM at $17.00/share
Oct 10, 2017
Purchase
Rivals
Compare David P. Meeker, M.D. with competitor CEOs and industry peers.